The present study describes the design and development of buoyant matrices of dipyridamole. The matrices were prepared by direct compression method using simplex lattice design as an optimization technique. Amount of HPMC K4M (X1), sodium bicarbonate (X2) and ethyl cellulose (X3) were used as the independent variables where floating lag time (Y1) and percentage drug release at 6h (Y2) were considered as the response variables. As per the simplex lattice design total 7 formulations were formulated. Matrices were evaluated for physical parameters, in-vitro buoyancy, in-vitro drug release, water uptake studies. Drug release data was fitted into different kinetic models. The results of response variables were statistically evaluated using design expert 8.0 software. Polynomial models were generated for all the response variables using multiple linear regression analysis (MLRA) approach. A statistical model incorporating 7 interactive terms was used to evaluate the responses. The results of response variables are expressed for model analysis by Scheffe's special cubic model. Graphical representation was done by response surface plots and contour plots. The resulted model equation showed that factor X1 responsible for prolongation of drug release. On the basis of acceptance criteria the formulation coded by DP3 was selected as a promising formulation from the simplex lattice batches which fitted best to zero order release kinetic model.
INTRODUCTION
There has been considerable research over the last decade on the possibility of controlled and site-specific delivery to the GIT by controlling the gastrointestinal transit of orally administered dosage forms using gastroretentive drug delivery system. Such gastroretentive drug delivery system possesses the ability of retaining the drug in GIT particularly, in the stomach for long periods (Arora et al., 2005) . Many drugs show poor bioavailability in the presence of intestinal metabolic enzymes like cytochrome P450 (CYP3A), abundantly present in the intestinal epithelium. Their activity decreases longitudinally along the small intestine, with levels rising slightly from the duodenum to the jejunum and declining in the ileum and colon (Hou et al., 2003) . A number of oral controlled release systems have been developed to improve the delivery of drugs to the systemic circulation (Gupta et. al., 2002 , Ritchel W.A et al 1991 .
Although such systems can control precisely and predictably the drug release rate for extended period of time, even over a number of days, they do not always perform satisfactorily if they pass through the drug absorption site e.g. the small intestine, before the release of loaded drug is complete. (Palin et al 1985 , Hou et al 2003 Thus, attention must be given to prolong the residence time of the system to achieve complete drug release in GIT as well as to modulate the drug release rate as predicted by the system in order to obtain an ideal oral control release system (Singh et al., 2000) . Several approaches to extend the gastric retention time have been developed including an intragastric floating system, a high density system, bioadhesive polymers (Chitnis et al., 1991) , mucoadhesive system (Chowdary et al., 2000) , a magnetic system, celluloses, gums (Greminger et al., 1980) and a superporous hydrogel system. An important issue in development of these systems is how to avoid inter-unit and intersubject variations in G.I residence time (Ahuja et al., 1997 , Fix et al., 1993 ). An ion exchange resins loaded with bicarbonate also contributing for gastric retention, which, on contact with media containing hydrochloric acid, release carbon dioxide causing the resin to float (Atyabi et al., 1996) .
Another problem is how to improve the absorption of poorly absorbed drug by using such systems. Various Gastroretentive dosage forms have been formulated against stomach specific H. pylori infection (Bardonnet et al., 2006) . Variability in G.I transit time is concern for oral controlled drug delivery systems (Gupta et al 2002) . Drugs with narrow absorption window in GI tract are particularly susceptible to variation in both bioavailability and time to achieve peak plasma levels (Deshpande et al., 1997) . Oral controlled release systems continue to be the most popular ones among all the drug delivery systems. The principle of buoyant preparation offers a simple and practical approach to achieve increased gastric residence time for the dosage form and controlled drug release (Cargill et. al., 1988) . Dipyridamole (DP) is a poorly water soluble weak base with pKa of 6.4. DP inhibits thrombus formation when given chronically and causes vasodilation when given at high doses over short time (Pillay et. al., 1998) . The extent of absorption of dipyridamole was remarkably lower when gastric pH was continuously elevated to 6.0, whereas absorption increased when gastric pH temporarily decreased to 1.8 (Chen et al., 2000 , Timmermans et al 1994 . So, it would be beneficial to develop floating drug delivery system which prolongs the gastric residence time and releases drug in proximal GI tract where absorption of dipyridamole is more confined and this rationale was considered for preparation of buoyant matrices based on Simple lattice design which is a simplex-shaped design having multiple mixture components. Simple lattice design is a mixture design. (Singh et.al. 2004) 
MATERIALS AND METHODS
Dipyridamole was received from Zydus Cadilla (Ahmedabad-India), HPMC K4M and Ethyl Cellulose was obtained from Colorcon (Goa-India). Other materials were purchased from the commercial sources: Sodium bicarbonate and lactose from Loba chemie (Mumbai-India), other reagents and solvents used were of analytical grade. Buffer and its dilutions were prepared with double-distilled water.
Experimental design
A Simplex Lattice Design (SLD) was adopted to optimize the formulation variables. In this design 3 factors were evaluated by changing their concentrations simultaneously and keeping total concentration constant (Figure1) (Patel et. al., 2007 , Prajapati et al 2009 .
The amounts of matrix forming agent (HPMC K4M, X 1 ), gas-generating agent (sodium bicarbonate, X 2 ), and floating enhancer (ethyl cellulose, X 3 ) were selected as independent variables. The preliminary trial batches were carried out to decide the levels of each independent variable ( were taken as response variables. 
Preparation of Buoyant Matrices
Different batches of tablets were prepared according to the SLD. Matrix tablets with a constant theoretical weight of 325 mg were obtained using a six station rotary tablet compression machine (JM-6, JMC, Mumbai, India) with flat-faced punches of 11.0 mm diameter. Compaction was accomplished by direct compression of drug-polymers blends previously mixed for 15 min using a tumbler mixer. For each batch, 20 randomly taken tablets were checked for weight uniformity, thickness, hardness and friability.
In vitro dissolution studies
Dissolution studies were conducted in triplicate using standard USP Paddle (Type II) dissolution apparatus (Electrolab). In all the dissolution studies, the paddles were rotated at a speed of 100 rpm in 900 ml simulated gastric fluid (SGF) at 37±0.5 0 C. At appropriate time intervals, 10 ml of the mixture was withdrawn and filtered. The removed samples were analyzed at 284 nm by UV-Vis spectrophotometer (UV 530 JASCO). Dissolution kinetic studies were carried out using PCP DISSO software.
Floating Lag Time (FLT) Study
Tablet immersed in beaker containing 900 ml 0.1 N HCl maintained at 37 ºC. The time required for the tablet to rise to the surface and float was determined as floating lag time (Oth et. al. 1992) .
Water Uptake (Swelling Index) Study
Swelling systems are studied for the water uptake and subsequent swelling. The swelling behavior of a dosage unit can be measured by studying its weight gain or water uptake (WU). The study is done by immersing the dosage form in simulated gastric fluid at 37 °C and determining these factors at regular intervals. The dimensional changes can be measured in terms of the increase in tablet diameter and/or thickness over time. WU is measured in terms of percent weight gain, as given by the 
Statistical Analysis and Optimization
The results from simplex lattice design were evaluated using Design Expert 8.0 Software. Polynomial models were generated for all the response variables using multiple linear regression analysis (MLRA) approach. The general MLRA model is represented by, Y = β 0 + β 1 X 1 + β 2 X 2 + β 3 X 3 + β 12 X 1 X 2 + β 23 X 2 X 3 + β 13 X 1 X 3 + β 123 X 1 X 2 X 3
Where Y is the dependent variable, β 0 is the arithmetic mean response of the 7 runs, and β i is the estimated coefficient for the factor Xi. The main effects (X 1 , X 2 , and X 3 ) represent the average result of changing 1 factor at a time from its low to high value. The interaction terms (X 1 X 2 , X 2 X 3 , X 1 X 3 , and X 1 X 2 X 3 ) show how the response changes when 2 or more factors are simultaneously changed (Prajapati et al 2009) . The statistical analysis of the simplex lattice design batches was performed by multiple linear regression analysis using Design Expert V 8.0 software.
RESULTS AND DISCUSSION

Physical Evaluation and Assay of Tablet Formulations
All tablet formulations were evaluated for various physical parameters and assay before proceeding further. The assayed content of drug in various formulations was within limit. (IP Limit-not less than 90% and not more than 110%). Table 2 includes the value of (Mean ± SD) of weights, hardness, thickness and drug content of all 7 formulations prepared using SLD. Thus all physical parameters of the compressed tablets were quite within control. 
In-vitro Dissolution Study and FLT Study
The dissolution data of batches DP1 to DP7 were fitted to zero order, first-order, Hixon-Crowell and Korsmeyer and Peppas models. The results of F statistics were used to select the most appropriate model. Cumulative drug release of all formulations is shown in Figure 2 .
The mechanism involved in buoyancy of the tablet is the entrapment of carbon dioxide gas induced by sodium bicarbonate after reaction with acidic dissolution medium (0.1N HCl). The gas is trapped and protected within the gel formed by hydration of polymer thus decreasing the density of the tablet below 1gm/cm 3 and the tablet becomes buoyant. The results of response variables are shown in Table 3 the values fo FLT (90.0 to 172 sec) and Rel 6h (88.1 to 98.32%), they are strongly depends on independent variables. 
Swelling Index (Water Uptake Study)
The swelling behavior of all the formulations was studied. The study was carried out for 6h and the swelling indices at time interval of 1, 2, 4 and 6h were determined. The results of swelling indices are shown in Figure 3 . 
Mathematical Modeling
The statistical analysis of simplex lattice design batches was performed by MLRA. The results can be expressed for model analysis by Scheffe's special cubic model for two response variables. FLT-Y 1 , (Sec) =+107.00 X 1 +146.00 X 2 +172.00 X 3 -14.00 X 1 X 2 -142.00 X 1 X 3 -276.00 X 2 X 3 +981.00 X 1 X 2 X 3 REL 6h -Y 2 (%) =+98.32 X 1 +88.10 X 2 +86.66 X 3 -14.12 X 1 X 2 +0.52 X 1 X 3 +37.12 X 2 X 3 +21.33 X 1 X 2 X 3
Response Surface Analysis
Figures 4A and 5A are the 3D Response Surface Plot, while figures 4B and 5B are the corresponding contour plot for the FLT and Rel 6h . The equation for FLT suggests that the factor X 1 has more significant effect on FLT. From the equation of Rel 6h , it can be concluded that X 1 has a more important role in prolonging the release. On the basis of acceptance criteria the formulation DP3 was selected as a promising formulation from the simplex lattice batches. These types of plots are useful in study of the effects of two factors on the response at one time. 
CONCLUSION
The floating matrices of Dipyridamole were prepared by direct compression method. Regulated drug release in zero order manner with bounancy of matrices attained in the current study indicates that bouyant matrices of Dipyridamole can successfully employed as floating controlled release drug delivery with minimum experimentation using simplex lattice design. The special cubic model equation for FLT suggests that the factor X 1 has more significant effect on FLT. From the equation for Rel 6h, it can be concluded that X 1 has a more important role in prolonging the drug release retardation. Conclusively, the current study attained that, successful development of dipyridamole, which improves the bioavalability by providing absorption in upper GIT by adopting a systematic formulation approach.
